SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                   Form 10-QSB

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 1996

Commission file number 0-21151


                           PROFILE TECHNOLOGIES, INC.
         ---------------------------------------------------------------
        (Exact name of small business issuer as specified in its charter)

           DELAWARE                                     91-1418002
-------------------------------                      -----------------
(State or other jurisdiction of                       (I.R.S. Employer
 incorporation or organization)                       Identification No.)


1077 Northern Blvd., Manhasset, NY                          11576
---------------------------------------                    --------
(Address of principal executive offices)                  (Zip Code)


                                  516-365-1909
                            -------------------------
                           (Issuer's telephone number)


Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the  registrant  was required to file such reports) and (2) has been
subject to such filing requirements for the past 90 days. Yes   X   No
                                                              -----    -----

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date.

     There were 4,212,600 shares of common stock issued and outstanding on March
10, 1997.

Transitional Small Business Disclosure Format
(Check one):

Yes        No   X
    -----     -----

                                                       

<PAGE>

<TABLE>
<CAPTION>

Item 1.  Financial Statements


                           PROFILE TECHNOLOGIES, INC.
                       (Formerly Pipeline Profiles, Ltd.)
                        (A Development Stage Enterprise)

                            Condensed Balance Sheets
======================================================================================
                                                             December 31,     June 30,
                                                                1996           1996
--------------------------------------------------------------------------------------
                                    Assets                   (unaudited)
                                    ------                                                 

<S>                                                           <C>            <C>   

Current assets:
     Cash and cash equivalents                                $ 25,077       212,689    
     Contract work in progress                                  30,000          --
     Prepaid expenses                                              530           249
                                                              ----------------------
        Total current assets                                    55,607       212,938

Property and equipment, net                                     24,487        34,443
Patents                                                        118,813       118,361
Deferred offering costs                                        127,499        95,864
                                                              ----------------------
                                                              $326,406       461,606    
                                                              ======================

                      Liabilities and Stockholders' Equity
                      ------------------------------------

Current liabilities:
     Accounts payable - stockholder                              2,500        14,654
     Accounts payable                                            2,535         4,540
     Accrued liabilities                                        63,673        52,699
     Accrued wages                                              15,750          --
                                                              ----------------------
        Total current liabilities                               84,458        71,893
                                                              ----------------------

Stockholders' equity:
     Common stock, $0.001 par value 
     Authorized 10,000,000 shares; issued                        3,213         3,213
     and outstanding 3,212,600 shares at
     December 31, 1996 and  June 30,1996
     Additional paid-in capital                              2,343,508     1,784,354
     Deficit accumulated during the development stage       (2,104,773)   (1,397,854)
                                                             -----------------------
        Total stockholders' equity                             241,948       389,713


------------------------------------------------------------------------------------
                                                              $326,406       461,606    
====================================================================================

See accompanying notes to condensed financial statements.
</TABLE>

<PAGE>
<TABLE>
<CAPTION>


                                     PROFILE TECHNOLOGIES, INC.
                                 (Formerly Pipeline Profiles, Ltd.)
                                  (A Development Stage Enterprise)

                                 Condensed Statements of Operations
                                            (unaudited)


-----------------------------------------------------------------------------------------------------------------------------------
                                                        Period from
                                                        July 1, 1988    
                                                       (inception)            Three months ended              Six months ended
                                                         through                  December 31                    December 31
                                                        December 31,         ---------------------           -------------------
                                                            1996             1996             1995           1996           1995
----------------------------------------------------------------------------------------------------------------------------------
<S>                                                 <C>                      <C>             <C>            <C>            <C>  
Revenues - testing services and research and        $     462,189              -             21,500         30,000         37,500  
     development fees
                                                    -------------------------------------------------------------------------------

Costs and expenses:
     Research and development                           1,203,616           51,573           39,233         118,166        84,267
     General and administrative                           516,374           34,811           37,018          60,941        60,874
     Excess of fair market value over exercise            350,000           50,000              -            50,000           -
         price of extended and assigned
         existing common stock purchase
         warrants
     Fair value of common stock purchase                  509,154          509,154              -           509,154           -
         warrants granted to consultants
                                                    -------------------------------------------------------------------------------
              Total costs and expenses                  2,579,144          645,538           76,251         738,261       145,141
                                                    -------------------------------------------------------------------------------
              Loss from operations                     (2,116,955)        (645,538)         (54,751)       (708,261)     (107,641)
                                                    -------------------------------------------------------------------------------

Interest income                                            12,082              287              940           1,342         2,055
Other income                                                  100              -                -               -             -
                                                    -------------------------------------------------------------------------------
              Net loss                              $  (2,104,773)        (645,251)         (53,811)       (706,919)     (105,586)
                                                    -------------------------------------------------------------------------------

Net loss per share                                                       $    (.17)            (.01)           (.19)         (.03)
                                                                         ==========================================================
     
     Weighted average common and common share                            3,756,350        3,693,683       3,756,350     3,687,017
     equivalents outstanding
===================================================================================================================================



See accompanying notes to condensed financial statements.


</TABLE>
<PAGE>
<TABLE>
<CAPTION>

                                                           PROFILE TECHNOLOGIES, INC.
                                                       (Formerly Pipeline Profiles, Ltd.)
                                                        (A Development Stage Enterprise)

                                                        Statements of Stockholders' Equity

-----------------------------------------------------------------------------------------------------------------------------------
                                                                                                              Deficit
                                                                                                             accumulated    Total
                                                                          Common stock         Additional    during the    stock-
                                                                  -----------------------        paid-in     development   holders'
                                                                    Shares       Amount          capital       stage       equity
-----------------------------------------------------------------------------------------------------------------------------------
<S>                                                               <C>          <C>              <C>            <C>          <C>
Sale at inception (July 1, 1988), $.0005 per share                1,000,000    $      500          --            --             500
Sale of common stock in July, $.0005 per share                      600,000           300          --            --             300
Sale of common stock in September, $.25 per share                   400,000         1,200        98,800          --         100,000
Net loss                                                               --            --            --         (85,749)      (85,749)
                                                                 ------------------------------------------------------------------
Balances at June 30, 1989                                         2,000,000         2,000        98,800       (85,749)       15,051
Sale of common stock in September, $.25 per share                    80,000            80        19,920          --          20,000
Net loss                                                               --            --            --         (13,683)      (13,683)
                                                                 ------------------------------------------------------------------
Balances at June 30, 1990                                         2,080,000         2,080       118,720       (99,432)       21,368
Sale of common stock in October, $.25 per share                     114,000           114        28,386          --          28,500
Issuance of common stock for services in November,
$.25 per share                                                       40,000            40         9,960          --          10,000
Net loss                                                               --            --            --         (30,593)      (30,593)
                                                                 ------------------------------------------------------------------
Balances at June 30, 1991                                         2,234,000         2,234       157,066      (130,025)       29,275
Sale of common stock in September, $.625 per share                  296,000           296       184,704          --         185,000
Sale of common stock in May, $1.50 share share                      141,268           141       211,761          --         211,902
Net loss                                                               --            --            --        (267,186)     (267,186)
                                                                 ------------------------------------------------------------------
Balances at June 30, 1992                                         2,671,268         2,671       553,531      (397,211)      158,991
Sale of common stock in January, $1.50 per share                     51,000            51        76,449          --          76,500
Net loss                                                               --            --            --        (132,905)     (132,905)
                                                                 ------------------------------------------------------------------
Balances at June 30, 1993                                         2,722,268         2,722       629,980      (530,116)      102,586
Net loss                                                               --            --            --         (13,503)      (13,503)
                                                                 ------------------------------------------------------------------
Balances at June 30, 1994                                         2,722,268         2,722       629,980      (543,619)       89,083
Repurchases of common stock in October                              (16,000)          (16)      (13,984)         --         (14,000)
Sale of common stock in December, $1.75 per share,                  268,332           269       447,196          --         447,465
net of issuance costs of $22,115
Excess of fair value over exercise price of existing                   --            --         210,000          --         210,000
common stock purchase warrants extended in December
Net loss                                                               --            --            --        (453,382)     (453,382)
                                                                 ------------------------------------------------------------------
Balances at June 30, 1995                                         2,974,600         2,975     1,273,192      (997,001)      279,166
Issuance of common stock for services in October,                    20,000            20        19,980          --          20,000
$1.00 per share
Sale of common stock in December-March, $2.00 per                   218,000           218       401,182          --         401,400
share, net of issuance costs of $34,600
Excess of fair value over exercise price of existing                   --            --          90,000          --          90,000
common purchase warrants extended in March
Net loss                                                               --            --            --        (400,853)     (400,853)
                                                                 ------------------------------------------------------------------
Balances at June 30, 1996                                         3,212,600         3,213     1,784,354    (1,397,854)      389,713
Fair value of common stock purchase warrants granted                   --            --         509,154          --         509,154
to consultants (unaudited)
Excess of fair market value over exercise price of                     --            --          50,000          --          50,000
existing common stock purchase warrants assigned
by principal stockholder to others (unaudited)
Net loss (unaudited)                                                   --            --            --        (706,919)     (706,919)
-----------------------------------------------------------------------------------------------------------------------------------
Balances at December 31, 1996 (unaudited)                         3,212,600    $    3,213     2,343,508    (2,104,773)      241,948
===================================================================================================================================
                                                                                                                         
</TABLE>

See accompanying notes to condensed financial statements.



<PAGE>
<TABLE>
<CAPTION>
                                                         PROFILE TECHNOLOGIES, INC.
                                                     (Formerly Pipeline Profiles, Ltd.)
                                                      (A Development Stage Enterprise)

                                                     Condensed Statements of Cash Flows
                                                                 (unaudited)


-----------------------------------------------------------------------------------------------------------------------------------
                                                                                 Period from
                                                                                 July 1, 1988
                                                                              (inception) through
                                                                                 December 31,             Six months ended
                                                                                                             December 31
                                                                                                    -------------------------------
                                                                                    1996              1996               1995
-----------------------------------------------------------------------------------------------------------------------------------
<S>                                                                            <C>                   <C>              <C>   
Cash flows from operating activities:
Net loss                                                                       $ (2,104,773)        (706,919)         (105,586)
Adjustments to reconcile net loss to net cash provided by (used in)
operating activities:
Depreciation and amortization                                                       106,821           10,301            10,495
Services received in exchange for common stock                                       10,000              -                 -
Excess of fair value over exercise price of extended and assigned                   350,000           50,000               -
existing common stock purchase warrants
Fair value of common stock purchase warrents granted to                             509,154          509,154               -
consultants
Changes in assets and liabilities:
Contract work in progress                                                           (30,000)         (30,000)          (12,500)
Accounts receivable - stockholder                                                     2,500          (12,154)              -
Prepaid expenses                                                                       (530)            (281)           (1,504)
Accounts payable                                                                      2,535           (2,005)             (624)
Accrued liabilities                                                                  63,673           10,974           (21,558)
Accrued wages                                                                        15,750           15,750           (11,555)
                                                                               ----------------------------------------------------
Net cash used in operating activities                                            (1,074,870)        (155,180)         (142,832)
                                                                               ----------------------------------------------------
Cash flows from financing activities:
Proceeds from issuance of common stock                                            1,471,567              -             180,000
Repurchase of common stock                                                          (14,000)             -                 -
Deferred IPO costs                                                                 (127,499)         (31,635)          (35,516)
Organization costs                                                                   (4,101)             -                 -
                                                                               ----------------------------------------------------
Net cash provided by (used in) financing activities                               1,325,967          (31,635)          144,484
                                                                               ----------------------------------------------------
Cash flows from investing activities:
Patents                                                                             (98,813)            (452)              -
Purchase of property and equipment                                                 (127,207)            (345)           (1,798)
                                                                               ----------------------------------------------------
Net cash used in investing activities                                              (226,020)            (797)           (1,798)
                                                                               ----------------------------------------------------
Increase (decrease) in cash and cash equivalents                                     25,077         (187,612)             (146)
Cash and cash equivalents at beginning of period                                      -              212,689           191,126
                                                                               ----------------------------------------------------
Cash and cash equivalents at end of period                                           25,077           25,077           190,980
                                                                               ----------------------------------------------------
Supplemental disclosure of noncash investing activities - patent costs in      $     20,000              -              20,000
exchange for common stock
===================================================================================================================================

</TABLE>

See accompanying notes to condensed financial statements.
<PAGE>

                           PROFILE TECHNOLOGIES, INC.
                       (Formerly Pipeline Profiles, Ltd.)
                        (A Development Stage Enterprise)

                    Notes to Condensed Financial Statements

--------------------------------------------------------------------------------

(1) Basis of Presentation

     The unaudited interim condensed financial statements and related notes have
     been prepared  pursuant to the  instructions  to  Form 10QSB.  Accordingly,
     certain information and footnote disclosures normally included in financial
     statements  prepared  in  accordance  with  generally  accepted  accounting
     principles   have  been  omitted   pursuant  to  such   instructions.   The
     accompanying  condensed  financial  statements  and related notes should be
     read in conjunction with the audited financial statements and notes thereto
     included in the  registration  statement  on Form SB-2 filed by the Company
     under the Securities Act of 1933 in February 1997.

     The  information  furnished  reflects,  in the opinion of  management,  all
     adjustments,  consisting of only normal  recurring  items,  necessary for a
     fair presentation of the results for the interim periods presented. Interim
     results are not necessarily indicative of results for a full year.

(2) Net Loss Per Share

     Net loss per share is computed by dividing net loss by the weighted average
     number of shares of common stock and common stock  equivalents  outstanding
     during each year. Common stock  equivalents  include all warrants and stock
     options  which would have a dilutive  effect,  applying the treasury  stock
     method. Additionally, common and common equivalent shares issued during the
     twelve months  immediately  preceding the anticipated date of the Company's
     initial public offering have been included in the calculation of common and
     common  equivalent  shares  as if they  were  outstanding  for all  periods
     presented,  including loss years where the impact of the incremental shares
     is  antidilutive,  using the treasury  stock  method and an initial  public
     offering price of $6 per share.

(3) Event Subsequent to December 31, 1996 - Financing

     On February  18, 1996,  the Company  closed an initial  public  offering of
     1,000,000  shares  of its  common  stock  at a price of $6 per  share.  Net
     proceeds to the Company were approximately $5,150,000.



<PAGE>

Item 2.  Management's Discussion and Analysis of Financial Condition and Results
         of Operations.
--------------------------------------------------------------------------------

GENERAL

     The Company is in the business of developing and commercializing  potential
processes for the non-destructive, non-invasive testing of both above ground and
buried  pipeline to evaluate the condition  and  integrity of the pipeline.  The
Company believes that the development of its pulse propagation  analyzer process
and the further refinement of the technology associated therewith has progressed
to the point where it believes  commercial  utilization  is feasible in the near
term.  The Company has not, as of yet,  obtained  significant  revenues from its
planned primary source of revenues and has no commercial  contracts in place for
the use of its  process  or  technology.  The goal of the  Company  has been the
establishment  of  technological  feasibility  associated  with its  services to
electronically  measure  corrosion in piping of all kinds. The Company's process
identifies  areas of corrosion,  areas that lack cathodic  protection  and areas
that may have defective coating on both below ground and above ground pipes. The
pulse  propagation  analyzer  consists  of  a  computer,   software  to  enhance
collection and processing of data, a precision multi-channel pulse generator and
a signal  analyzer.  During fiscal 1996, the Company began to see rapid progress
in the development of its technology and its ability to meet the expectations of
potential  customers.  By that time,  the  Company had begun to  accelerate  its
efforts  and expend  more  resources  to develop its  technology  faster.  Thus,
expenses and purchases of equipment have been  generally  increasing at a faster
pace than in prior periods.  The Company expects these trends to continue as its
technological  development  continues  at this  accelerated  pace.  The  Company
believes  that it attained  technological  feasibility  of its process  with the
completion of its research and development activity in a controlled  environment
in July of 1996.

     In order for the Company to obtain significant revenues from the use of its
technology,  the Company must establish a sales and marketing  organization that
is effective  and obtains  customers  for its pulse  propagation  analyzer.  The
Company must also be able to supply and train work crews in  sufficient  numbers
to satisfy the  requirements of its customers.  From inception  through December
31, 1996, the Company  incurred  losses of $2,104,773 and losses are expected to
continue at least through the third quarter of the year ending June 30, 1997; no
assurances can be given that losses will not continue thereafter.

RESULTS OF OPERATIONS

Quarter Ended December 31, 1996 Compared to the Quarter Ended December 31, 1995
-------------------------------------------------------------------------------

     The  Company  has no  revenues  for the  quarter  ended  December  31, 1996
compared to $21,500 in revenues for the quarter  ended  December  31, 1995.  The
loss from  operations  for the quarter  ended  December  31,  1996 was  $645,538
compared to a loss from operations of $54,751 for the quarter ended December 31,
1995. Of the operating loss of $645,538 for the quarter ended December 31, 1996,
$559,154,  or  86.6%,  of such  loss was  attributed  to  noncash,  nonrecurring
expenses  associated with the issuance of new common stock purchase  warrants to
certain officers,  directors or certain outside  consultants or to the extension
of already issued and outstanding common stock purchase  warrants.  Research and
development  expenses  increased to $51,573 for the quarter  ended  December 31,
1996 compared to $39,233 for the quarter ended December 31, 1995. This is

                                        2

<PAGE>



indicative  of increased  expenses  associated  with an increase in research and
development activity.  General and administrative expenses decreased slightly to
$34,811 for the quarter  ended  December  31, 1996 from  $37,018 for the quarter
ended December 31, 1995.

Six Months  Ended  December  31, 1996  Compared to Six Month Ended  December 31,
1995.
--------------------------------------------------------------------------------

     Revenues  decreased  slightly to $30,000 for the six months ended  December
31, 1996 from  $37,500 for the six months ended  December 31, 1995.  Revenues in
both six month periods were derived from research and  development  contracts or
demonstration contracts with two large multi-national oil companies. Total costs
and expenses for the six months ended  December 31, 1996 were $738,261  compared
to total costs and expenses of $145,141 for the quarter ended December 31, 1995.
Of the total  costs and  expenses  for the  quarter  ended  December  31,  1996,
$559,154,  or 75.7% were for noncash,  nonrecurring  charges associated with the
issuance or extension of common stock purchase  warrants.  Without giving effect
to such costs and  expenses,  total costs and  expenses for the six months ended
December  31, 1996 were  $179,107  compared to $145,141 for the six months ended
December 31, 1995. This represents an increase of $33,966 or 23.4%. Research and
development expenses increased to $118,166 for the six months ended December 31,
1996 from  $84,267 for the six months ended  December  31, 1995,  an increase of
$33,899 or 40.2%.  The  increase  is  primarily  due to an  increase in expenses
relating  to a  field  demonstration  of the  Company's  technology  for a large
multi-national  oil  company  in  Alaska  in  September  of  1996.  General  and
administrative  expenses were  generally  flat for the six months ended December
31, 1996 ($60,941) compared to the six months ended December 31, 1995 ($60,874).

     Management  believes  that both  revenues  and  expenses of the Company may
increase  during the fiscal  year  ending  June 30, 1997 if it is able to secure
contracts with customers, of which there is no assurance. The revenues earned by
the Company to date  principally  relate to research and development  activities
that  have  been  sponsored  by large  multi-national  oil  companies  and large
utilities.  These  activities  included field  research and  development at such
companies'  facilities.  These activities are likely to continue during the year
ending  June  30,  1997  and  for the  foreseeable  future.  Management  is also
vigorously working towards obtaining fee for service contracts,  which are hoped
to be the major source of the Company's  revenues.  If fee for service contracts
are obtained,  management expects its expenditures associated with personnel and
testing  equipment  will begin to rise.  In addition,  as the Company  begins to
actually  provide  fee  for  service  work,  additional  administrative  support
activities will increase together with related expenses.

LIQUIDITY AND CAPITAL RESOURCES

     Revenues for the period from July 1, 1988 (inception)  through December 31,
1996,  were $462,189  while expenses were  $2,579,144,  resulting in a loss from
operations,   since  inception,  of  $2,116,955.  Net  cash  used  in  operating
activities  from inception  through  December 31, 1996 was  $1,074,870.  Of this
amount, $80,649 was spent in the three month period ended December 31, 1996. For
the six months ended  December 31, 1996,  cash used in operations  was $155,180.
Thus, while the revenues derived from research and development activities funded
by  multi-national  oil companies and major  utilities  have been  indicative of
financial support for the Company's efforts to develop its technology, they have
not been sufficient to cover expenses.  Accordingly,  the Company has maintained
adequate liquidity and cash reserves through the private placement of its common
stock.

                                        3

<PAGE>

Such  offerings,  from  inception  through the period  ended  December 31, 1996,
totaled $1,471,567. In December 1994 the Company extended the expiration date on
certain Common Stock purchase  warrants which,  pursuant to the  requirements of
generally  accepted  accounting  principals,  resulted in the  recognition of an
additional  contribution  of capital in the amount of $210,000  together  with a
corresponding  charge  to  compensation  expense.  Such  warrants  were  further
extended  in the  quarter  ended  March 31,  1996 and the  Company  incurred  an
additional  expense of  $90,000  in  connection  therewith.  Additional  noncash
expenses relating to the issuance of new warrants or the extension of previously
issued  warrants in the amount of $559,154  were  incurred in the quarter  ended
December 31, 1996. These  transactions had no effect on aggregate  stockholders'
equity. The Company did not have difficulty  arranging for private placements of
its common stock in the past, and these placements provided sufficient liquidity
for the Company to operate.  Cash flow from investing  activity through December
31, 1996 was minimal because of a lack of cash assets. The Company has generally
been able to maintain a positive  working  capital  position  in between  common
stock  offerings  through  prudent  expense  control.  At December 31, 1996, the
Company had negative  working capital of $(28,851) and no long term  commitments
or material commitments for capital expenditures.

     In February of 1997, the Company  completed an initial  public  offering of
its common stock,  selling  1,000,000  shares at a price of $6.00 per share. Net
offering proceeds of approximately  $5,150,000 were realized by the Company from
this  public  offering.  Cash flow from  investing  activities  is  expected  to
increase  substantially  because the  Company,  pending  utilization  of the net
proceeds in  operations,  will invest such proceeds in  short-term,  high grade,
interest-bearing  instruments.  The Company  believes  that its current  capital
resources and liquidity are adequate for at least the next twelve months.  Other
than  equipment  purchases  for field  crews if the  Company  is  successful  in
obtaining  commercial  contracts,  the  Company  does  not have  any  plans  for
significant capital  expenditures.  To date, the Company has only obtained small
research and development contracts,  the proceeds of which were used to defray a
portion of the Company's research and development costs.

RESOURCES

     As of December 31, 1996 the Company did not have any  material  commitments
for capital  expenditures.  However, it is management's  intention to direct the
Company's  activities  towards obtaining fee for service  contracts,  which will
necessitate the Company attracting,  hiring,  training and outfitting  qualified
technicians. The Company's intention is to purchase such equipment for its field
crews for the foreseeable future, until such time as the scope of the operations
may require alternate  sources of financing such equipment.  The timing of these
events  is  dependent  upon the  Company's  ability  to obtain  fee for  service
contracts,   which  is  dependent  upon  the  Company's  continuing  ability  to
demonstrate the  effectiveness of its technology.  The Company believes that its
cash position is  sufficient to satisfy its operating  needs for the next twelve
months.  Management believes it is well on the way to reaching these milestones,
but there can be no assurance that the Company's process will be accepted within
any particular time frame, or at all. The Company recently  acquired  commercial
office  space in the  NewYork  City area and is  looking  for space to carry out
research and  development  activities  in Lynden,  Washington.  The Company will
incur increased expenses  associated with the leasing of such space. The Company
will also incur additional personnel expenses as it hires and trains field crews
and support personnel related to the successful receipt of commercial contracts.

                                        4

<PAGE>

                                     PART II

Item 1.  Legal Proceedings.

     The Company is not a party to any pending or threatened legal proceedings.

Item 2.  Changes in Securities.

     None.

Item 3.  Defaults Upon Senior Securities.

     None.

Item 4.  Submission of Matters to a Vote of Security Holders.

     None.

Item 5.  Other Information.

     None.

Item 6.  Exhibits and Reports on Form 8-K.

     (a) Exhibits.
             
              None

     (b) Reports on Form 8-K.

              None



                                        5

<PAGE>


                                   SIGNATURES

     In accordance  with the  requirements  of the Exchange Act, the  registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.



                                              PROFILE TECHNOLOGIES, INC.
                                                   (Registrant)


Date: March 24, 1997                          /s/  G.L. SCOTT
                                              ---------------------------------
                                              G.L. SCOTT
                                              Chief Executive Officer



                                              /s/  HENRY GEMINO
                                              ---------------------------------
                                              HENRY GEMINO
                                              Secretary-Treasurer
                                              Chief Financial Officer


                                        6